Patent Assignment
Reel/Frame 027341/0421
Merger
Recorded: 2011-12-06
Pages: 112
Assignor
BAYER HEALTHCARE AG
Executed: 2008-12-30
Assignee
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
MUELLERSTRASSE 178, BERLIN, 13353, GERMANY
Covered Property
(1)
Substituted 2,3-Dihydroimidazo[1,2-C]Quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Change of Name
Dec 6, 2011
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 027333/0860 →
Assignment of Assignor's Interest
May 30, 2013
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 030516/0512 →
Change of Address
Jun 12, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 064021/0344 →